A systematic review found that the risk of HBV infection associated with anti-HBc-positive grafts is 48% in naïve patients and 1.4% in those with previous infections (anti-HBc-positive and anti-HBs-positive), suggesting that antiviral prophylaxis is not mandatory in the latter group of patients [48]. The gene discussed is KRT88P; the disease is infection.